Seattle startup Nohla Therapeutics has raised another huge funding round as it moves its novel leukemia treatment closer to being approved by the FDA. The company added $45 million in… Read More
Seattle-based Nohla Therapeutics, a biotech startup spun out of the Fred Hutchinson Cancer Research Center, just announced a whopping $43.5 million Series A round, bringing the startup’s total funding to date… Read More
When a patient is diagnosed with Leukemia or another blood cancer, they generally undergo long, painful rounds of chemotherapy to eradicate the disease. But for many patients, the type of… Read More